Mode
Text Size
Log in / Sign up
N/A N=168 Randomized Treatment

Trans-obturator Mid-urethral Sling and the Single-incision Sling in Women With Stress Urinary Incontinence

Urinary Incontinence, Stress

Enrolled (actual)
168
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Percentage of Participants With Negative Cough Stress Test (CST) — 86.4; 83.1 percentage of participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
TOT - inside-out trans-obturator tape/sling (Device); SIS - Innovative fixation single incision sling (Device)
Age
Adult, Older Adult · 35+ yrs
Sex
Female
Sponsor
Brno University Hospital
Primary completion
Dec 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Participants With Negative Cough Stress Test (CST)
86.4; 83.1
PRIMARY
Patient Global Impression of Improvement (PGI-I) Score
1.4; 1.3
SECONDARY
Number of Participants With Major Perioperative Complications
0; 0
SECONDARY
Number of Participants With Major Postoperative Complications
0; 0

Summary

Mid-urethral slings (MUS) now represent a gold standard in the treatment of female stress urinary incontinence (SUI). Second generation trans-obturator slings (TOT) have proven to be as effective as retropubic tension-free vaginal tape (TVT) with fewer major complications. A third generation of the MUS inserted through a single vaginal incision (SIS) has become a means to overcome significant post-operative groin pain. Novel types of SIS with a more robust and adjustable anchoring mechanism can assure adequate long-lasting attachment to the obturator membrane (OM). Objective of this study was to compare an inside-out TOT with an innovative fixation SIS in randomized controlled trial on patients undergoing their primary surgery for urodynamic SUI.

Eligibility Criteria

Inclusion Criteria

Women with pure or predominant urodynamic stress urinary incontinence confirmed during filling cystometry by positive standardized cough stress test (CST) with urinary bladder filling of 250 ml in lithotomy position.

Exclusion Criteria

  • patients with predominant urge incontinence
  • patients with intrinsic sphincter deficiency (MUCP 2)
  • previous urinary incontinence surgery
  • previous pelvic organ prolapse surgery
  • presence of other pelvic organ pathology.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02506309). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search